Pacitti David purchased $100K of OBIO
Pacitti David purchased 20,000 shares of Orchestra BioMed Holdings, Inc. (OBIO) at $5.00 ($0.10M total) on 2026-11-09.
How this was made
The 30-second read
Why it matters
The filing provides fresh, primary‑source information about insider activity, but the transaction size is modest.
Market read
The news is a low‑impact insider purchase; relevance to traders is limited.
What to watch
If the director has private knowledge of upcoming milestones, the signal could be more material than the dollar amount suggests.
Background
SEC Form 4 filings disclose insider transactions. This filing reports a director's purchase of OBIO shares.
Ticker impact
Director Pacitti David bought 20,000 shares of OBIO at $5 each, a $100K purchase disclosed in a Form 4 filing.
likely slight upward pressure as the market prices in the director's confidence
The transaction size is small relative to market cap, but insider buying is a positive signal.
Market effects
Minimal impact on the biotech sector; insider activity is company‑specific.
No broader regional effect.
Limited to OBIO investors.
Counterpoint
The purchase is too small to move the stock; traders may ignore it.
Key entities
- CompanyOrchestra BioMed Holdings, Inc.
Biotech company listed on NASDAQ under ticker OBIO.
- PersonPacitti David
Director of OBIO who made the purchase.
